Chronic myeloid leukemia in India
P Ganesan, L Kumar - Journal of global oncology, 2017 - ascopubs.org
Background In the last decade, the use of imatinib has brought a paradigm shift in the
management of chronic myeloid leukemia (CML). In India, imatinib has been available for …
management of chronic myeloid leukemia (CML). In India, imatinib has been available for …
Present and future of molecular monitoring in chronic myeloid leukaemia
S Soverini, C De Benedittis, M Mancini… - British Journal of …, 2016 - Wiley Online Library
Currently, physicians treating chronic myeloid leukaemia (CML) patients can rely on a wide
spectrum of therapeutic options: the best use of such options is essential to achieve …
spectrum of therapeutic options: the best use of such options is essential to achieve …
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients
BM Rajamani, ESB Benjamin, A Abraham… - Scientific reports, 2020 - nature.com
Achieving early molecular response (EMR) has been shown to be associated with better
event free survival in patients with chronic phase chronic myeloid leukemia (CP-CML) on …
event free survival in patients with chronic phase chronic myeloid leukemia (CP-CML) on …
Molecular monitoring
S Soverini, G Rosti, M Baccarani… - Current hematologic …, 2014 - Springer
More and more potent therapeutic approaches demand more and more sophisticated
response monitoring. Soon after the introduction of the first tyrosine-kinase inhibitor (TKI) for …
response monitoring. Soon after the introduction of the first tyrosine-kinase inhibitor (TKI) for …
Prognostic value of MRD monitoring based on BCR-ABL1 copy numbers in Philadelphia chromosome positive acute lymphoblastic leukemia
AK Arunachalam, NB Janet, A Korula… - Leukemia & …, 2020 - Taylor & Francis
Assessment of measurable residual disease (MRD) has emerged as a powerful prognostic
tool in pediatric and adult acute lymphoblastic leukemia (ALL). In this single-centre …
tool in pediatric and adult acute lymphoblastic leukemia (ALL). In this single-centre …
Issues in current management of chronic myeloid leukemia: Importance of molecular monitoring on long term outcome
H Menon - South Asian journal of cancer, 2013 - thieme-connect.com
Monitoring of CML patients while on therapy is vitally important and ENL has come up with
specific guidelines for the same. Since we are currently talking about operational cure, this …
specific guidelines for the same. Since we are currently talking about operational cure, this …
Importance of early and deeper responses to long-term survival in CML patients: Implications of BCR-ABL testing in management of CML in Indian setting
MB Agarwal - Indian Journal of Medical and Paediatric …, 2014 - thieme-connect.com
The prognosis of patients with chronic myeloid leukemia (CML) has changed radically since
the advent of imatinib mesylate, a selective inhibitor of BCR-ABL tyrosine kinase. Shortly …
the advent of imatinib mesylate, a selective inhibitor of BCR-ABL tyrosine kinase. Shortly …
[PDF][PDF] Prognostic significance of micro RNA 150 marker in BCR-ABL positive chronic myeloid leukaemia patients on imatinib mesylate
OB Ezeanosike, O Afonne - International Journal of Contemporary …, 2017 - academia.edu
ABSTRACT Background: Micro-RNAs control gene expression by destabilizing targeted
transcripts and inhibiting their translation. In chronic myeloid leukaemia (CML), abnormal …
transcripts and inhibiting their translation. In chronic myeloid leukaemia (CML), abnormal …
[HTML][HTML] Importance of early and deeper responses to long-term survival in CML patients: Implications of BCR-ABL testing in management of CML in Indian setting
PS Kulkarni, K Das, N Agrawal, M Kala, R Khanduri… - ijmpo.org
The prognosis of patients with chronic myeloid leukemia (CML) has changed radically since
the advent of imatinib mesylate, a selective inhibitor of BCR-ABL tyrosine kinase. Shortly …
the advent of imatinib mesylate, a selective inhibitor of BCR-ABL tyrosine kinase. Shortly …
[引用][C] An Observational study of Non-adherence in Patients with Chronic Myeloid Leukemia on Treatment with Imatinib–Prevalence, Predictors and Outcomes.
K Anu - 2013 - Christian Medical College, Vellore